Yehuda Zelig
Algemeen Directeur bij Scigen (I.L.) Ltd.
Profiel
Yehuda Zelig is the founder of Valin Technologies Ltd.
He currently holds positions as Managing Director at Scigen (I.L.) Ltd., Director at Active P Ltd., and Senior Vice President at Biorest Ltd.
Previously, he held positions as Director at SciSparc Ltd.
and Vice President-Manufacturing & Scale Up at Biotechnology General (Israel) Ltd.
Mr. Zelig obtained an undergraduate degree from The Hebrew University of Jerusalem and an MBA from Technion Institute.
Actieve functies van Yehuda Zelig
| Bedrijven | Functie | Begin |
|---|---|---|
Scigen (I.L.) Ltd.
 Scigen (I.L.) Ltd. Pharmaceuticals: MajorHealth Technology Part of FDS Pharma LLP, Scigen (I.L.) Ltd. is an Israeli company that manufactures vaccines. The company is based in Rehovot, Israel. The CEO of the company is Yehuda Zelig. Scigen (I.L. was acquired by FDS Pharma LLP from SciGen Pte Ltd. on February 14, 2012 for $2 million. | Algemeen Directeur | 25-02-2010 |
| Biorest Ltd. | Corporate Officer/Principal | 25-02-2010 |
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Directeur/Bestuurslid | 03-03-2010 |
| Valin Technologies Ltd. | Oprichter | - |
Eerdere bekende functies van Yehuda Zelig
| Bedrijven | Functie | Einde |
|---|---|---|
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | - |
| SCISPARC LTD. | Directeur/Bestuurslid | - |
Opleiding van Yehuda Zelig
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Technion Institute | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SCISPARC LTD. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
Scigen (I.L.) Ltd.
Scigen (I.L.) Ltd. Pharmaceuticals: MajorHealth Technology Part of FDS Pharma LLP, Scigen (I.L.) Ltd. is an Israeli company that manufactures vaccines. The company is based in Rehovot, Israel. The CEO of the company is Yehuda Zelig. Scigen (I.L. was acquired by FDS Pharma LLP from SciGen Pte Ltd. on February 14, 2012 for $2 million. | Health Technology |
| Biorest Ltd. | |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
| Valin Technologies Ltd. |
